,
your personalized virtual assistant to find clinical trials. Go head, 
David Russell, MD
Institute for Neurodegenerative DisordersNew haven, Connecticut - 06510 (203 401 4362) |
- CLINICAL TRIALS 3
- CONDITIONS3
- INTERVENTIONS2
- SINCE2010
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
September 2010 - February 2011
Study to Identify Clinical Imaging and Biologic Markers of Parkinson Disease Progression
June 2010 - December 2017
Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
March 2010 - November 2010
Alzheimer Disease
Parkinson Disease
Disease Progression
[18f] Mni-558
Drug: [18f] Pbr111
